Cargando…
Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis
Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-1...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985867/ https://www.ncbi.nlm.nih.gov/pubmed/33583450 http://dx.doi.org/10.1017/S0950268821000376 |
_version_ | 1783668332614909952 |
---|---|
author | Gao, Ya Chen, Yamin Liu, Ming Niu, Mingming Song, Ziwei Yan, Meili Tian, Jinhui |
author_facet | Gao, Ya Chen, Yamin Liu, Ming Niu, Mingming Song, Ziwei Yan, Meili Tian, Jinhui |
author_sort | Gao, Ya |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-19. We performed a systematic literature search of four electronic databases and included studies reporting the prevalence of nervous system diseases in COVID-19 patients with severe and non-severe disease or among survivors and non-survivors. The included studies were pooled into a meta-analysis to calculate the odds ratio (OR) with 95% confidence intervals (95%CI). We included 69 studies involving 17 879 patients. The nervous system diseases were associated with COVID-19 severity (OR = 3.19, 95%CI: 2.37 to 4.30, P < 0.001) and mortality (OR = 3.75, 95%CI: 2.68 to 5.25, P < 0.001). Specifically, compared with the patients without cerebrovascular disease, patients with cerebrovascular disease infected with COVID-19 had a higher risk of severity (OR = 3.10, 95%CI: 2.21 to 4.36, P < 0.001) and mortality (OR = 3.45, 95% CI: 2.46 to 4.84, P < 0.001). Stroke was associated with severe COVID-19 disease (OR = 1.95, 95%CI: 1.11 to 3.42, P = 0.020). No significant differences were found for the prevalence of epilepsy (OR = 1.00, 95%CI: 0.42 to 2.35, P = 0.994) and dementia (OR = 2.39, 95%CI: 0.55 to 10.48, P = 0.247) between non-severe and severe COVID-19 patients. There was no significant association between stroke (OR = 1.79, 95%CI: 0.76 to 4.23, P = 0.185), epilepsy (OR = 2.08, 95%CI: 0.08 to 50.91, P = 0.654) and COVID-19 mortality. In conclusion, nervous system diseases and cerebrovascular disease were associated with severity and mortality of patients with COVID-19. There might be confounding factors that influence the relationship between nervous system diseases and COVID-19 severity as well as mortality. |
format | Online Article Text |
id | pubmed-7985867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-79858672021-03-25 Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis Gao, Ya Chen, Yamin Liu, Ming Niu, Mingming Song, Ziwei Yan, Meili Tian, Jinhui Epidemiol Infect Review Coronavirus disease 2019 (COVID-19) has become a global pandemic. Previous studies showed that comorbidities in patients with COVID-19 are risk factors for adverse outcomes. This study aimed to clarify the association between nervous system diseases and severity or mortality in patients with COVID-19. We performed a systematic literature search of four electronic databases and included studies reporting the prevalence of nervous system diseases in COVID-19 patients with severe and non-severe disease or among survivors and non-survivors. The included studies were pooled into a meta-analysis to calculate the odds ratio (OR) with 95% confidence intervals (95%CI). We included 69 studies involving 17 879 patients. The nervous system diseases were associated with COVID-19 severity (OR = 3.19, 95%CI: 2.37 to 4.30, P < 0.001) and mortality (OR = 3.75, 95%CI: 2.68 to 5.25, P < 0.001). Specifically, compared with the patients without cerebrovascular disease, patients with cerebrovascular disease infected with COVID-19 had a higher risk of severity (OR = 3.10, 95%CI: 2.21 to 4.36, P < 0.001) and mortality (OR = 3.45, 95% CI: 2.46 to 4.84, P < 0.001). Stroke was associated with severe COVID-19 disease (OR = 1.95, 95%CI: 1.11 to 3.42, P = 0.020). No significant differences were found for the prevalence of epilepsy (OR = 1.00, 95%CI: 0.42 to 2.35, P = 0.994) and dementia (OR = 2.39, 95%CI: 0.55 to 10.48, P = 0.247) between non-severe and severe COVID-19 patients. There was no significant association between stroke (OR = 1.79, 95%CI: 0.76 to 4.23, P = 0.185), epilepsy (OR = 2.08, 95%CI: 0.08 to 50.91, P = 0.654) and COVID-19 mortality. In conclusion, nervous system diseases and cerebrovascular disease were associated with severity and mortality of patients with COVID-19. There might be confounding factors that influence the relationship between nervous system diseases and COVID-19 severity as well as mortality. Cambridge University Press 2021-02-15 /pmc/articles/PMC7985867/ /pubmed/33583450 http://dx.doi.org/10.1017/S0950268821000376 Text en © The Author(s) 2021 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Gao, Ya Chen, Yamin Liu, Ming Niu, Mingming Song, Ziwei Yan, Meili Tian, Jinhui Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis |
title | Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis |
title_full | Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis |
title_fullStr | Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis |
title_full_unstemmed | Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis |
title_short | Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis |
title_sort | nervous system diseases are associated with the severity and mortality of patients with covid-19: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985867/ https://www.ncbi.nlm.nih.gov/pubmed/33583450 http://dx.doi.org/10.1017/S0950268821000376 |
work_keys_str_mv | AT gaoya nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis AT chenyamin nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis AT liuming nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis AT niumingming nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis AT songziwei nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis AT yanmeili nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis AT tianjinhui nervoussystemdiseasesareassociatedwiththeseverityandmortalityofpatientswithcovid19asystematicreviewandmetaanalysis |